The primary goal of this initiative is to develop non-invasive measures of brain activity in preclinical species for assessing functional domains that may be impaired in mental illnesses.
Recent Posts
- The Psychology of Conspiracy Theories During COVID-19
- Scientific Meeting » Workshop: Gene-based Therapeutics for Rare Genetic Neurodevelopmental Psychiatric Disorders
- In a Relationship, but Lonely All the Same
- Scientific Meeting » NIMH Livestream Event: Managing Stress and Anxiety
- Video » The NIMH Director’s Innovation Speaker Series: Pursuing an Innovation Agenda: A New Healthcare Architecture